
The Competition Commission of India (CCI) has decided to adjourn matters listed for hearing, amid the coronavirus scare. The hearings have been adjourned till March 31.
However, urgent matters have been exempted from adjournment, according to a circular issued by the regulator on Tuesday, March 17.
In the wake of the coronavirus pandemic, that has affected more than one hundred-thousand people worldwide, many entities have taken various measures, including opting for meetings through video-conference.
The Securities Appellate Tribunal (SAT), on Monday, announced it would hear only urgent matters and restricted courtroom access till March 27.
“In order to prevent spread of COVID-19, as a precautionary measure, it has been decided by the competent authority to adjourn matters listed for hearing (excluding urgent matters, if any) till March 31,2020.
“Rescheduled dates will be communicated in due course,” the Tribunal stated.
As part of precautionary measures, the regulator stated non-essential visits are discouraged and that visitors “would be required to give a self-declaration in prescribed format.”
To curb spreading of the virus, various travel advisories have been issued and many events postponed.
Full Content: Outlook India
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas